Accès à distance ? S'identifier sur le proxy UCLouvain
Effects of CYP2C9*5,*6,*8 and *11 polymorphisms on losartan oxidation among black Africans
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2004 |
| Language | Anglais |
| Conference | "8th World Congress of Clinical Pharmacology and Therapeutics", Brisbane (Australia) (Aug 01-06, 2004) |
| Journal information | "Clinical and Experimental Pharmacology & Physiology" - Vol. 31, no. 11, p. A219-A219 (2004) |
| Peer reviewed | yes |
| issn | 0305-1870 |
| e-issn | 1440-1681 |
| Publisher | Blackwell Publishing Asia (Carlton) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL |
| Links |
| Bibliographic reference | Allabi, Aurel C ; Horsmans, Yves ; Gala, Jean-Luc ; Babaoglu, MO ; Bozkurt, A ; et. al. Effects of CYP2C9*5,*6,*8 and *11 polymorphisms on losartan oxidation among black Africans.8th World Congress of Clinical Pharmacology and Therapeutics (Brisbane (Australia), Aug 01-06, 2004). In: Clinical and Experimental Pharmacology & Physiology, Vol. 31, no. 11, p. A219-A219 (2004) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/61102 |